Sign in
4

Changes in Ownership

Actinium Pharmaceuticals, Inc. Filed Acc 0001213900-25-028230

Options or other derivatives

  • Director returned 50,000 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Almenoff June Sherie · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-03-31 Returned to the company : show line 1 in the form Stock Option (Right to Buy) −50,000 0 D
Loading xslF345X05/ownership.xml…